MedPath

PROMETHEGAN

PROMETHAZINE HYDROCHLORIDE SUPPOSITORIES, USP Rx Only

Approved
Approval ID

636bb9bc-0cc5-4d6a-85be-6471acf01ffc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2023

Manufacturers
FDA

Cosette Pharmaceuticals, Inc.

DUNS: 116918230

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

promethazine hydrochloride

PRODUCT DETAILS

NDC Product Code0713-0132
Application NumberANDA087165
Marketing CategoryC73584
Route of AdministrationRECTAL
Effective DateNovember 30, 2023
Generic Namepromethazine hydrochloride

INGREDIENTS (4)

ASCORBYL PALMITATEInactive
Code: QN83US2B0N
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
HARD FATInactive
Code: 8334LX7S21
Classification: IACT
PROMETHAZINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 1
Code: R61ZEH7I1I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROMETHEGAN - FDA Drug Approval Details